Sign in to continue:

Tuesday, March 10th, 2026

Calisa Acquisition Corp to Merge with GoodVision AI Inc, Forming Global Cloud and AI Infrastructure Leader




Calisa Acquisition Corp and GoodVision AI Announce \$180 Million Merger Agreement

Calisa Acquisition Corp Enters \$180 Million Merger Agreement with GoodVision AI Inc

New York, NY, March 9, 2026 — Calisa Acquisition Corp (NASDAQ: ALIS), a special purpose acquisition company (SPAC), has officially announced the execution of a Business Combination Agreement with GoodVision AI Inc, a rapidly growing global provider of cloud-computing and artificial intelligence (AI) infrastructure solutions.

Key Highlights of the Merger

  • Transaction Structure: Calisa Merger Sub, a wholly owned subsidiary of ALIS, will merge with and into GoodVision AI. The surviving entity, GoodVision AI, will become a wholly-owned subsidiary of ALIS.
  • Valuation: GoodVision AI shareholders will receive ALIS ordinary shares valued at \$180 million as part of the transaction.
  • Board Approval: The boards of directors of both companies have unanimously approved the deal, which is expected to close in the second half of 2026, subject to regulatory and shareholder approvals, and other customary closing conditions.
  • Post-Closing: Upon completion, the combined entity will operate under the name GoodVision AI Inc and continue to trade as a NASDAQ-listed public company under a new ticker symbol.
  • Leadership Continuity: GoodVision AI’s executive management team will remain in place to lead the combined company.

About GoodVision AI Inc

Founded in 2019 by David Wang (formerly of IBM, AWS, and Tencent Cloud), GoodVision AI has become a prominent provider in the cloud and AI infrastructure market. The company operates primarily from the United States, with additional offices in Germany, Japan, Singapore, and other Asia-Pacific regions.

GoodVision AI’s clientele spans high-growth sectors such as gaming, video, cross-border e-commerce, and crypto technology, all of which require robust, flexible, and scalable cloud and AI infrastructure to support global operations.

Evolution and Strategic Focus

  • The company initially built its business on multi-cloud professional services, acting as a redistributor of cloud capacity from major global providers including Google Cloud, AWS, Alibaba Cloud, and Tencent Cloud. This approach allowed GoodVision AI to offer competitive pricing, cross-platform access, and responsive global technical support.
  • With surging global demand for AI computing, GoodVision AI has shifted towards developing advanced, hybrid cloud and edge-computing solutions, culminating in the launch of the GoodVision AI Scheduling Platform. This proprietary system optimizes AI inference workloads across a range of large language models (LLMs), computing layers, and edge devices, integrating both closed- and open-source models to reduce costs, improve latency, and address data-privacy requirements.
  • The company is expanding its infrastructure by building new data center capacity, deploying GPU-based inference clusters and edge nodes, and forging strategic partnerships—such as its collaboration with EdgeAI, a distributed edge-computing provider.
  • GoodVision AI aims to build a global distribution network combining hybrid cloud resources, edge devices, and a multi-model AI routing engine, enabling efficient and cost-effective AI deployment worldwide.

Executive Statements

David Wang, CEO of GoodVision AI, stated: “We are thrilled to announce this merger. The AI market is growing rapidly, and listing publicly via this business combination provides us with strategic capital to accelerate the development of our AI-inference platform and significantly expand our presence in global cloud computing. Partnering with ALIS and Hongfei’s team aligns perfectly with our vision to deliver greater value to our customers and shareholders.”

Hongfei Zhang, CEO of ALIS, commented: “This proposed merger followed a comprehensive search and evaluation process. We believe GoodVision AI offers the most compelling opportunity to deliver shareholder value, providing our investors with an equity stake in a pioneering, high-growth AI and cloud-computing company.”

Advisors

  • Graubard Miller is serving as U.S. legal advisor to ALIS.
  • VCL Law LLP is serving as legal advisor to GoodVision AI.
  • EarlyBirdCapital Inc. is serving as financial advisor to ALIS.

Key Considerations and Potential Share Price Impact

  • Substantial Valuation: The \$180 million valuation for GoodVision AI reflects significant confidence in the company’s growth trajectory and market opportunity. Shareholders should note that the issuance of ALIS shares for this transaction may affect the share count and potentially the per-share value post-merger.
  • Regulatory and Shareholder Approvals: The transaction is subject to various approvals, including from the shareholders of both ALIS and GoodVision AI, and may not close if these are not obtained.
  • Market Positioning: Post-merger, the combined company will be one of the few global AI and cloud infrastructure providers publicly traded on NASDAQ, potentially increasing visibility, liquidity, and analyst coverage.
  • Risks: Risks include the possibility that the transaction does not close, changes in the regulatory or competitive environment, and the ability of the combined company to integrate operations and achieve projected synergies.
  • Forward-Looking Statements: Investors are cautioned that the press release contains forward-looking statements subject to risks and uncertainties. Actual results may differ materially from projections.

Next Steps and Additional Information

  • ALIS intends to file a Registration Statement with the SEC, which will include a proxy statement/prospectus for shareholders. Investors should review all documents carefully before making any voting or investment decisions.
  • No offer or solicitation to buy or sell securities is being made at this time. Any offer will be made only by means of a prospectus meeting SEC requirements.
  • Investors and shareholders can obtain free copies of these documents through the SEC’s website (www.sec.gov) and by contacting ALIS directly.

For Investor and Media Inquiries:

Email: [email protected]


Disclaimer: This article is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy any securities. Forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those indicated. Investors are urged to read all relevant SEC filings and consult with their financial advisors before making any investment decisions.




View Calisa Acquisition Corp Historical chart here



Hormel Foods Reports Q1 2026 Results: $3 Billion Net Sales, Segment Profit & Organic Sales Growth Insights

Hormel Foods Q1 2026 Financial Results – Investor Analysis Hormel Foods Reports Strong Q1 2026 Results: Key Insights for Investors Financial Highlights Net Sales: Achieved \$3 billion in net sales, representing organic net sales...

Esperion Therapeutics and Corstasis Therapeutics Inc. Agreement and Plan of Merger: Key Definitions, Terms, and Transaction Details

Esperion Therapeutics, Inc. – Detailed Report Analysis (Potential Market-Moving Event) Esperion Therapeutics, Inc. (NASDAQ: ESPR) – Merger Agreement Announcement Key Points for Investors Merger Agreement Filed: Esperion Therapeutics, Inc. has filed a Form 8-K...

Compass Therapeutics 2025 10-K: Clinical-Stage Oncology Pipeline, Risks, and Regulatory Overview

Compass Therapeutics, Inc. 2025 Annual Report – Investor Highlights Compass Therapeutics, Inc. (CMPX) 2025 Annual Report: Key Investor Takeaways Overview Compass Therapeutics, Inc., headquartered at 80 Guest Street, Boston, MA, is a clinical-stage biotechnology...

   Ad